Literature DB >> 22462773

Myeloperoxidase-derived chlorinating species induce protein carbamylation through decomposition of thiocyanate and urea: novel pathways generating dysfunctional high-density lipoprotein.

Michael Holzer1, Klaus Zangger, Dalia El-Gamal, Veronika Binder, Sanja Curcic, Viktoria Konya, Rufina Schuligoi, Akos Heinemann, Gunther Marsche.   

Abstract

AIMS: Protein carbamylation through cyanate is considered as playing a causal role in promoting cardiovascular disease. We recently observed that the phagocyte protein myeloperoxidase (MPO) specifically induces high-density lipoprotein (HDL) carbamylation, rather than chlorination, in human atherosclerotic lesions, raising the possibility that MPO-derived chlorinating species are involved in cyanate formation.
RESULTS: Here, we show that MPO-derived chlorinating species rapidly decompose the plasma components thiocyanate (SCN) and urea, thereby promoting (lipo)protein carbamylation. Strikingly, the presence of physiologic concentrations of SCN completely prevented MPO-induced 3-chlorotyrosine formation in HDL. SCN scavenged a 2.5-fold molar excess of hypochlorous acid, promoting HDL carbamylation, but not chlorination. Cyanate significantly impaired (i) HDL's ability to activate lecithin-cholesterol acyltransferase; (ii) the activity of paraoxonase, a major HDL-associated anti-inflammatory enzyme; and (iii) the antioxidative activity of HDL. INNOVATION: Here, we report that MPO-derived chlorinating species preferentially induce protein carbamylation-rather than chlorination-in the presence of physiologically relevant SCN concentrations. The carbamylation of HDL results in the loss of its anti-inflammatory and antioxidative activities.
CONCLUSION: MPO-mediated decomposition of SCN and/or urea might be a relevant mechanism for generating dysfunctional HDL in human disease.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22462773      PMCID: PMC3810648          DOI: 10.1089/ars.2011.4403

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  39 in total

1.  ON THE REVERSIBLE REACTION OF CYANATE WITH SULFHYDRYL GROUPS AND THE DETERMINATION OF NH2-TERMINAL CYSTEINE AND CYSTINE IN PROTEINS.

Authors:  G R STARK
Journal:  J Biol Chem       Date:  1964-05       Impact factor: 5.157

2.  Uremia alters HDL composition and function.

Authors:  Michael Holzer; Ruth Birner-Gruenberger; Tatjana Stojakovic; Dalia El-Gamal; Veronika Binder; Christian Wadsack; Akos Heinemann; Gunther Marsche
Journal:  J Am Soc Nephrol       Date:  2011-07-29       Impact factor: 10.121

3.  Novel function of lecithin-cholesterol acyltransferase. Hydrolysis of oxidized polar phospholipids generated during lipoprotein oxidation.

Authors:  J Goyal; K Wang; M Liu; P V Subbaiah
Journal:  J Biol Chem       Date:  1997-06-27       Impact factor: 5.157

4.  Protein concentration in interstitial and lymphatic fluids from the subcutaneous tissue.

Authors:  G Rutili; K E Arfors
Journal:  Acta Physiol Scand       Date:  1977-01

Review 5.  Antiatherogenic function of HDL particle subpopulations: focus on antioxidative activities.

Authors:  Anatol Kontush; M John Chapman
Journal:  Curr Opin Lipidol       Date:  2010-08       Impact factor: 4.776

6.  Oxidation of high density lipoproteins. II. Evidence for direct reduction of lipid hydroperoxides by methionine residues of apolipoproteins AI and AII.

Authors:  B Garner; A R Waldeck; P K Witting; K A Rye; R Stocker
Journal:  J Biol Chem       Date:  1998-03-13       Impact factor: 5.157

7.  Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase.

Authors:  M Aviram; M Rosenblat; C L Bisgaier; R S Newton; S L Primo-Parmo; B N La Du
Journal:  J Clin Invest       Date:  1998-04-15       Impact factor: 14.808

8.  Redox buffering of hypochlorous acid by thiocyanate in physiologic fluids.

Authors:  Michael T Ashby; Amy C Carlson; M Jared Scott
Journal:  J Am Chem Soc       Date:  2004-12-15       Impact factor: 15.419

9.  Eosinophil peroxidase oxidation of thiocyanate. Characterization of major reaction products and a potential sulfhydryl-targeted cytotoxicity system.

Authors:  M Arlandson; T Decker; V A Roongta; L Bonilla; K H Mayo; J C MacPherson; S L Hazen; A Slungaard
Journal:  J Biol Chem       Date:  2001-01-05       Impact factor: 5.157

10.  Determination of serum levels of dietary thiocyanate.

Authors:  F Olea; P Parras
Journal:  J Anal Toxicol       Date:  1992 Jul-Aug       Impact factor: 3.367

View more
  34 in total

1.  Carbamylated Lipoproteins and Progression of Diabetic Kidney Disease.

Authors:  Kathryn C B Tan; Ching-Lung Cheung; Alan C H Lee; Joanne K Y Lam; Ying Wong; Sammy W M Shiu
Journal:  Clin J Am Soc Nephrol       Date:  2020-02-19       Impact factor: 8.237

Review 2.  Residual Cardiovascular Risk in Chronic Kidney Disease: Role of High-density Lipoprotein.

Authors:  Valentina Kon; Haichun Yang; Sergio Fazio
Journal:  Arch Med Res       Date:  2015-05-23       Impact factor: 2.235

3.  Human myeloperoxidase (hMPO) is expressed in neurons in the substantia nigra in Parkinson's disease and in the hMPO-α-synuclein-A53T mouse model, correlating with increased nitration and aggregation of α-synuclein and exacerbation of motor impairment.

Authors:  Richard A Maki; Michael Holzer; Khatereh Motamedchaboki; Ernst Malle; Eliezer Masliah; Gunther Marsche; Wanda F Reynolds
Journal:  Free Radic Biol Med       Date:  2019-06-06       Impact factor: 7.376

Review 4.  Mechanisms and consequences of carbamoylation.

Authors:  Sigurd Delanghe; Joris R Delanghe; Reinhart Speeckaert; Wim Van Biesen; Marijn M Speeckaert
Journal:  Nat Rev Nephrol       Date:  2017-07-31       Impact factor: 28.314

5.  Dialysis Modalities and HDL Composition and Function.

Authors:  Michael Holzer; Gernot Schilcher; Sanja Curcic; Markus Trieb; Senka Ljubojevic; Tatjana Stojakovic; Hubert Scharnagl; Chantal M Kopecky; Alexander R Rosenkranz; Akos Heinemann; Gunther Marsche
Journal:  J Am Soc Nephrol       Date:  2015-03-05       Impact factor: 10.121

6.  Carbamylated LL-37 as a modulator of the immune response.

Authors:  Catalin Koro; Annelie Hellvard; Nicolas Delaleu; Veronika Binder; Carsten Scavenius; Brith Bergum; Izabela Główczyk; Helen M Roberts; Iain L C Chapple; Melissa M Grant; Maria Rapala-Kozik; Kinga Klaga; Jan J Enghild; Jan Potempa; Piotr Mydel
Journal:  Innate Immun       Date:  2016-02-15       Impact factor: 2.680

Review 7.  ESRD-induced dyslipidemia-Should management of lipid disorders differ in dialysis patients?

Authors:  Hamid Moradi; Elani Streja; Nosratola D Vaziri
Journal:  Semin Dial       Date:  2018-04-29       Impact factor: 3.455

8.  Psoriasis alters HDL composition and cholesterol efflux capacity.

Authors:  Michael Holzer; Peter Wolf; Sanja Curcic; Ruth Birner-Gruenberger; Wolfgang Weger; Martin Inzinger; Dalia El-Gamal; Christian Wadsack; Akos Heinemann; Gunther Marsche
Journal:  J Lipid Res       Date:  2012-05-30       Impact factor: 5.922

Review 9.  HDL abnormalities in nephrotic syndrome and chronic kidney disease.

Authors:  Nosratola D Vaziri
Journal:  Nat Rev Nephrol       Date:  2015-11-16       Impact factor: 28.314

Review 10.  The Role of Nonenzymatic Post-translational Protein Modifications in Uremic Vascular Calcification.

Authors:  Kenneth Lim; Sahir Kalim
Journal:  Adv Chronic Kidney Dis       Date:  2019-11       Impact factor: 3.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.